Biomarker Discovery via N-Glycoproteomics

Area of Science:

• Molecular Biology
• Biochemistry
• Proteomics

Background:

• Posttranslational modifications (PTMs) are vital for protein function and cellular regulation.
• N-linked glycosylation, a complex PTM, influences critical cellular processes including protein folding, trafficking, and signaling.
• Aberrations in N-linked glycosylation sites are linked to human genetic diseases, notably cancer.

Purpose of the Study:

• To explore the potential of mass spectrometry (MS)-based proteomics for identifying novel cancer biomarkers.
• To describe methods for selectively identifying aberrant N-linked glycopeptides.
• To advance the discovery and clinical application of tumor markers.

Main Methods:

• Utilizing high-throughput quantitative proteome profiling tools.
• Employing mass spectrometry (MS)-based proteomics for glycopeptide analysis.
• Implementing Solid-phase extraction of N-glycopeptides (SPEG) for selective enrichment.

Main Results:

• Demonstrated the capacity of MS-based proteomics to identify aberrant N-linked glycopeptides.
• Highlighted the potential of these glycopeptides as single tumor markers.
• Proposed hypotheses for revolutionizing biomarker discovery and clinical translation.

Conclusions:

• Aberrant N-linked glycopeptides can be selectively identified using MS-based proteomics.
• This approach holds significant promise for discovering novel cancer biomarkers.
• The findings could accelerate the clinical implementation of new diagnostic and prognostic tools.